Advertisement · 728 × 90
#
Hashtag
#OligonucleotideTherapy
Advertisement · 728 × 90
Preview
ten23 health and Neumirna partner to advance RNA therapy for epilepsy The collaboration seeks to advance NMT.001, an RNA-based therapy targeting microRNAs involved in drug-resistant epilepsy.

ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.

#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences

0 0 0 0
Preview
ten23 health and Neumirna partner to advance RNA therapy for epilepsy The collaboration seeks to advance NMT.001, an RNA-based therapy targeting microRNAs involved in drug-resistant epilepsy.

ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.

#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences

0 0 0 0

🎯 Takeaway: a minimal, targetable 6-nt motif gates PKD1 dose and disease progression.
This mutation-agnostic, precision strategy offers a blueprint for oligonucleotide therapy in haploinsufficient disorders beyond ADPKD
#miRNA #OligonucleotideTherapy #RNAtherapeutics #Nephrology

0 0 0 0